Kaleido Biosciences, Inc.

KLDO · OTC
Analyze with AI
12/31/2021
9/30/2021
6/30/2021
3/31/2021
Operating Activities
Net Income-$20-$23-$24-$23
Dep. & Amort.$1$1$1$1
Deferred Tax-$0-$0$0$0
Stock-Based Comp.$2$2$2$4
Change in WC$1$4$1-$6
Other Non-Cash$0$0$0$0
Operating Cash Flow-$17-$16-$20-$24
Investing Activities
PP&E Inv.-$0-$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0-$0-$0-$0
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$0$0$70
Stock Repurch.-$0-$0-$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0-$0$0
Financing Cash Flow-$0-$0-$0$0
Forex Effect$0$0$0$0
Net Chg. in Cash-$17-$16-$20$46
Supplemental Information
Beg. Cash$58$74$95$48
End Cash$41$58$74$95
Free Cash Flow-$18-$16-$20-$24
Kaleido Biosciences, Inc. (KLDO) Financial Statements & Key Stats | AlphaPilot